Navigation Links
Israeli Colorectal Cancer Expert Unveils Promising Research Dramatically Extending Patients’ Life Expectancy
Date:5/16/2019

A leading cancer expert at Israel’s national hospital has generated cutting-edge research that could potentially extend the life expectancy of colorectal cancer patients worldwide.

Prof. Dan Aderka, the head of the Gastrointestinal Cancer Service at Sheba Medical Center, Tel HaShomer in Israel, and a chief specialist in the field of digestive system oncology, conducted his pioneering research in the Institute of Oncology in collaboration with international associates.

First published in the UK's prestigious The Lancet Oncology Journal, Prof. Aderka’s findings resolve a decade-long debate by providing conclusive data concerning which combinations of biological medicine and chemotherapy have the most successful outcome of extending the life expectancy of colorectal patients.

“Our hope is that this new discovery will mark the dawn of a new era for colorectal cancer patients and extended life expectancies,” said Prof. Aderka. “Essentially, the conclusion of our findings calls into question and unhinges the sequence of the two primary biological medications previously used in treatments for years – Avastin and Erbitux. Now we know that if the appropriate drugs are administered in a specific order, patients’ life expectancy is increased dramatically. This discovery is life-changing.”

Prof. Aderka studied colorectal cancer patients with different types of incurable tumors, classifying them into four groups. In one of the groups, the combination of Avastin with chemotherapy extended life expectancy with a 21-month average, and the combination of Erbitox with chemotherapy increased life expectancy with a 40-month average.

Yet, another focus group within Prof. Aderka’s study that suffered from a different type of colorectal cancer tumor yielded dissimilar results. In this group, Avastin extended life expectancy with a 22-month average, and Erbitox alone only increased life expectancy by an average of 11 months.

“We thought that one treatment across the board would work for all colorectal cancer patients, and because of this, for years we did not know how to use the drugs to their full potential,” said Prof. Aderka. “This research shows that chemotherapy and biological drugs are not a one-size-fits all treatment.”

About Sheba Medical Center, Tel HaShomer
Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East. Sheba is the only medical center in Israel that combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research and education. As a university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, it welcomes people from all over the world indiscriminately. In 2019, Newsweek magazine named Sheba one of the top ten hospitals in the world. To learn more, visit: eng.sheba.co.il.

Read the full story at https://www.prweb.com/releases/israeli_colorectal_cancer_expert_unveils_promising_research_dramatically_extending_patients_life_expectancy/prweb16318032.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. World Renowned Israeli Researcher Shares Groundbreaking Research on the Obesity Epidemic and its Connection to Alzheimer’s Disease
2. In Twist of Fate and Friendship, Israeli Doctor and Palestinian Family Help Save Each Other
3. The Israeli Pharma Company Therapix, is Joined by Five Internationally Renowned Experts, From Israel and the World, in the Field of Psychiatry and Tourette
4. Gamida Cell Announces $4.4 Million Grant from the Israeli Government
5. Oramed to Present at Oppenheimer Annual Israeli Conference
6. Israeli Start-up That Treats Knee Cartilage Injuries Raises $15M for U.S. Pivotal Clinical Trial
7. RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments
8. RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
9. Untold News, an American Non-Profit, Awards $10,000 (U.S.) Each to Israeli Inventors of a Cancer Bullet, a Metal Ligament Prosthesis, and a Bendable Plastic Touch Screen Display In First Annual Ceremony
10. CareFusion To Invest $100 Million In Israeli Infusion Pump Maker
11. Alaska Structures Delivers $3.5 Million Dollar Mobile Field Hospital to Israeli Defense Forces to Increase Medical Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2019)... (PRWEB) , ... August 17, 2019 , ... ... Companies—the Inc. 5000 , Foster Crown, LLC Ranks No. 2502 on the 2019 ... revealed that Foster Crown, LLC, the boutique physician recruitment firm is No. 2502 ...
(Date:8/16/2019)... ... August 16, 2019 , ... Healthpointe is proud to announce ... (EMDR). This therapeutic technique aims to reduce psychological distress, promote healing, and strengthen ... (PTSD), depression, chronic pain, anxiety, and grief. EMDR is applicable for a ...
(Date:8/16/2019)... ... 2019 , ... The American Academy of Emergency Medicine Physician ... as a member group. , SBEP is a longstanding democratic group that has ... out the AAEM-PG for administrative and practice management support that will help preserve ...
Breaking Medicine Technology:
(Date:8/21/2019)... ... 2019 , ... Alsana , an integrative and data-driven ... 2020. Alsana will offer an eating disorder treatment program for adults 18+ with ... program will provide a continuum of care as clients progress through the stages ...
(Date:8/21/2019)... ANTONIO (PRWEB) , ... August 21, 2019 , ... Photoprotective ... skin care products. This water-based ingredient is currently used in skincare products such as ... PPT. The award-winning product addresses the growing need to protect the skin from blue ...
(Date:8/21/2019)... Calif. (PRWEB) , ... August ... ... to announce a revolutionary advancement in automated x-ray inspection technology: HDRX imaging. ... and minimized false rejects. More importantly, HDRX can deliver high image resolution ...
(Date:8/19/2019)... ... August 19, 2019 , ... AJG Packaging, ... announced the availability of resealable single-dose vials for a multitude of applications. The ... consists of five resealable breakaway vials and are available in either polyethylene or ...
(Date:8/19/2019)... ... August 19, 2019 , ... American Society for ... cosmetic procedures in 2018 – 7.5 percent more than 2017 and a 60 ... Survey on Dermatologic Procedures revealed skin cancer treatments are persistently the ...
Breaking Medicine News(10 mins):